Rare
lephants
Screener
Toggle theme
Perrigo Company plc
PRGO
·
Healthcare, Drug Manufacturers - General, Ireland
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Cash Flow History
Net Cash Flow Breakdown
Net Cash Flow
Cash Flow
›
Net Cash Flow Breakdown
Net Cash Flow Breakdown
Chart
Table
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
Total Cash from Operations:
$1.68B
Line Item
Value
% of Total
Capital Expenditures
$160.4M
9.5%
Business Acquisitions
$1.50B
89.3%
Net Cash Flow
$19.6M
1.2%
Download CSV
